Chinese vaccine by Sinovac against coronavirus

Turkey continues to test China’s coronavirus vaccine

The tests will last 2 weeks. Health workers and nursing homes will be the first to receive the vaccine, which will be voluntary.

Turkey’s health authorities continue to test the coronavirus vaccine developed by the Chinese pharmaceutical company Sinovac, of which the first 3 million doses arrived in Turkey last week, before starting the vaccination plan against the COVID-19 pandemic.

In a statement released by the Ministry of Health, it reported that the vaccines are being tested and subjected to quality controls following international standards, in which their quality, effectiveness and reliability are analysed once stored and supplied, following the specifications of the company.

“Vaccine tests were launched the same day the doses were delivered,” the ministry said in a statement released today. The tests will last at least two weeks – counting from their arrival on December 30 – and “if the doses prove to be safe, they will be available for vaccination once they receive approval for emergency use from the TİTCK (Turkish Medicines and Medical Devices Institution)”.

The agreement signed between Turkey and Sinovac specifies the delivery of a total of 50 million doses; Ankara has also recently reached another agreement with BioNTech-Pfizer to purchase 30 million doses of its vaccine, of which 4.5 million doses will be delivered before the end of March. In addition, the Turkish government is studying the possibility of developing its own vaccine in collaboration with BioNTech, a German company founded by a married couple of Turkish origin.

The plan to supply the coronavirus vaccine in Turkey specifies that health personnel and nursing homes will be the first to receive the vaccine, which will be administered through family health centres as well as public and private hospitals. The vaccine will be voluntary and will be administered to those who request it by appointment, in two doses separated by 28 days.